SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2ija'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EKJ_H_ACTH3006_0
(BETA-CARBONIC
ANHYDRASE)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 6 GLN A 130
ASP A 122
HIS A 107
CYH A  68
None
None
ACM  A 301 (-4.0A)
ACM  A 301 (-1.7A)
1.47A 1ekjG-2ijaA:
undetectable
1ekjH-2ijaA:
undetectable
1ekjG-2ijaA:
20.13
1ekjH-2ijaA:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EKJ_H_ACTH3006_0
(BETA-CARBONIC
ANHYDRASE)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 6 GLN A 130
ASP A 122
VAL A  71
HIS A 107
None
None
None
ACM  A 301 (-4.0A)
1.23A 1ekjG-2ijaA:
undetectable
1ekjH-2ijaA:
undetectable
1ekjG-2ijaA:
20.13
1ekjH-2ijaA:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XOT_B_VDNB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
5 / 12 TYR A 190
LEU A 135
ILE A 189
SER A 184
SER A 128
None
1.45A 1xotB-2ijaA:
undetectable
1xotB-2ijaA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CEO_A_T44A1395_1
(THYROXINE-BINDING
GLOBULIN)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
5 / 11 LEU A 275
LEU A 279
LEU A 234
LEU A 267
ARG A  64
None
0.99A 2ceoA-2ijaA:
undetectable
2ceoA-2ijaA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XN6_A_T44A1370_1
(THYROXINE-BINDING
GLOBULIN)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
5 / 10 LEU A 275
LEU A 279
LEU A 234
LEU A 267
ARG A  64
None
1.10A 2xn6A-2ijaA:
undetectable
2xn6B-2ijaA:
undetectable
2xn6A-2ijaA:
21.07
2xn6B-2ijaA:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_A_ZMRA1776_2
(NEURAMINIDASE A)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 6 ASP A 251
ILE A 253
LEU A 181
TYR A 129
None
1.07A 2ya7A-2ijaA:
undetectable
2ya7A-2ijaA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_B_ZMRB1776_2
(NEURAMINIDASE A)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 6 ASP A 251
ILE A 253
LEU A 181
TYR A 129
None
1.06A 2ya7B-2ijaA:
undetectable
2ya7B-2ijaA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_D_ZMRD1776_2
(NEURAMINIDASE A)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 6 ASP A 251
ILE A 253
LEU A 181
TYR A 129
None
1.06A 2ya7D-2ijaA:
undetectable
2ya7D-2ijaA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HCR_B_CHDB924_0
(FERROCHELATASE,
MITOCHONDRIAL)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 7 LEU A  69
ARG A 197
SER A 215
GLY A 104
ACM  A 301 ( 4.8A)
None
None
None
0.98A 3hcrB-2ijaA:
undetectable
3hcrB-2ijaA:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K8M_A_ACRA730_1
(ALPHA-AMYLASE, SUSG)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 5 ARG A 151
TYR A 160
LYS A 188
ASP A 162
None
1.03A 3k8mA-2ijaA:
0.0
3k8mA-2ijaA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K8M_B_ACRB830_1
(ALPHA-AMYLASE, SUSG)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 5 ARG A 151
TYR A 160
LYS A 188
ASP A 162
None
0.96A 3k8mB-2ijaA:
0.0
3k8mB-2ijaA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 6 PHE A  37
CYH A  68
VAL A  93
PHE A 217
None
ACM  A 301 (-1.7A)
None
ACM  A 301 (-4.2A)
0.70A 3ltwA-2ijaA:
32.5
3ltwA-2ijaA:
29.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N2O_C_AG2C1002_1
(BIOSYNTHETIC
ARGININE
DECARBOXYLASE)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 8 HIS A  43
SER A 219
ASP A 179
LEU A 180
None
1.05A 3n2oC-2ijaA:
undetectable
3n2oD-2ijaA:
undetectable
3n2oC-2ijaA:
19.44
3n2oD-2ijaA:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A3U_B_ACTB1358_0
(NADH:FLAVIN
OXIDOREDUCTASE/NADH
OXIDASE)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 7 ILE A  32
GLN A 130
GLY A 124
VAL A  71
None
1.01A 4a3uB-2ijaA:
undetectable
4a3uB-2ijaA:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_A_ZPCA1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 7 TYR A  94
VAL A  93
ILE A 106
GLU A 182
UNX  A 502 (-4.3A)
None
None
None
1.07A 4a97E-2ijaA:
undetectable
4a97E-2ijaA:
24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_I_ZPCI1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 7 TYR A  94
VAL A  93
ILE A 106
GLU A 182
UNX  A 502 (-4.3A)
None
None
None
1.08A 4a97H-2ijaA:
undetectable
4a97H-2ijaA:
24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_J_ZPCJ1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 8 TYR A  94
VAL A  93
ILE A 106
GLU A 182
UNX  A 502 (-4.3A)
None
None
None
1.04A 4a97I-2ijaA:
undetectable
4a97I-2ijaA:
24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TWJ_C_SAMC201_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE H)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
5 / 12 LEU A 234
LEU A  40
LEU A 258
SER A 259
VAL A 266
None
1.16A 5twjC-2ijaA:
undetectable
5twjC-2ijaA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CE2_B_SVRB202_1
()
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 8 LEU A 152
LEU A 137
GLY A  90
ARG A 197
None
0.93A 6ce2A-2ijaA:
undetectable
6ce2A-2ijaA:
16.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNE_B_ACRB602_2
(-)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 8 VAL A  59
TRP A  67
HIS A  73
ASN A  72
None
ACM  A 301 (-4.7A)
None
None
1.17A 6gneB-2ijaA:
undetectable
6gneB-2ijaA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_W_CHDW102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1

(Homo
sapiens)
4 / 5 ARG A 197
MET A  88
THR A  87
LEU A 110
None
1.36A 6nknW-2ijaA:
undetectable
6nknW-2ijaA:
12.28